Successful treatment of acute portal vein thrombosis with rivaroxaban

Thrombosis and Haemostasis

Volumn 110, Issue 4, 2013, Pages 626-627

  Pannach, Sven ^a   Babatz, Jana ^a   Beyer Westendorf, Jan ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RIVAROXABAN;

ADULT; ARTICLE; CASE REPORT; DYSPHAGIA; ECHOGRAPHY; EPIGASTRIC PAIN; FATIGUE; HUMAN; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RECANALIZATION;

ACUTE DISEASE; ANTICOAGULANTS; DISEASE-FREE SURVIVAL; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; NEOVASCULARIZATION, PHYSIOLOGIC; PORTAL VEIN; RECOVERY OF FUNCTION; REGIONAL BLOOD FLOW; THIOPHENES; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS;

EID: 84884899201     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-05-0407     Document Type: Article

References (5)

1. Thatipelli MR, McBane RD, Hodge DO, et al. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol; 8: 200-205.
2. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e419S-94S.
3. Riva N, Donadini MP, Dentali F, et al. Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res 2012; 130 (Suppl 1): S1-3.
4. Turpie AG, Kreutz R, Llau J, et al. Management consensus guidance for the use of rivaroxaban-an oral, direct factor Xa inhibitor. Thromb Haemost 2012; 108: 876-886.
5. Hammerstingl C, Potzsch B, Nickenig G. Resolution of giant left atrial appendage thrombus with rivaroxaban. Thromb Haemost 2013; 109: 583-584.